INTRODUCTION
in the genomes of modern humans and other primates are reasonable candidates, particularly given the recent observation that endogenous murine leukemia viruses bear signatures of mutation by the single murine APOBEC3 protein (18).
Among HERVs, the HERV-K(HML-2) family is thought to be the youngest, with multiple human-specific and polymorphic insertions that indicate replication in human ancestors within the past few million years (3, 4, 15, 37) . None of the known proviruses in modern humans are capable of replication and, therefore, many aspects of HERV-K biology could not previously be studied. Recently, however, we and others have derived a consensus HERV-K(HML-2) sequence by aligning human specific proviruses and synthesized this pseudo-ancestral proviral construct (11, 21) . We have shown that this virus, named HERV-K CON , encodes and expresses all viral proteins necessary for infection and have derived an experimental system in which HERV-K CON can be shown to infect numerous cell lines in a single-cycle assay. Using this approach, we also showed that human APOBEC3F (hA3F) protein can inhibit HERV-K CON infection in single-cycle, transient overexpression assays (21) .
In this study, we expand our study of ancient retrovirus:host interactions to other APOBEC3 family members and find that several APOBEC3 proteins are intrinsically capable of mutating and inhibiting infection by HERV-K. We also present striking evidence that two HERV-K(HML-2) proviruses that are present in the human genome have been subjected to hypermutation by APOBEC3G (hA3G), in a manner that can be accurately recapitulated during HERV-K replication in vitro. Along with evidence of hA3G hypermutation in HIV-1 and HBV infected patient samples (17, 35, 38) , this is a rare example of the antiretroviral effects of hA3G in a natural infection setting, and the first example where inactivation of ancient retroviruses in humans by hA3G can be demonstrated. 
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MATERIALS AND METHODS

Cell lines and transfection
293T cells were maintained in DMEM supplemented with 10% fetal calf serum and gentamicin.
CEM cells were maintained in RPMI supplemented with 10% fetal calf serum and gentamicin.
For transfection, 293T cells were seeded at around 1.5 × 10 6 cells in six-well plates and transfected using polyethylenimine as previously described (21) . Medium was changed 5 h after transfection with fresh media containing 5µM sodium butyrate, and virus-containing supernatants were collected after an additional 40 h.
Expression plasmids
The HERV-K CON vector genome plasmid CCGBX is a derivative of the previously described CHKCG (21) and was constructed by inserting CMVP-EGFP cassette into XbaI and SwaI sites of CHKCG, resulting in vector genome that is slightly smaller than CHKCG and gives higher infectious titers. CCGBX-P was derived from CCGBX by inserting a 53 bp HIV-1 derived sequence (GATCTGAGCCTGGGAGCTCTCTGGCTTGTGACTCTGGTAACTAGAGATCCCTC) into the 5' end of the 3' LTR to allow specific amplification of newly introduced HERV-K CON sequences upon infection of human cells. The insertion was made using overlap extension PCR, and SwaI and NheI restriction sites in the HERV-K CON vector sequence. HERV-K protein expression vectors (pCRVI/Con Gag-PR-Pol and pCR3.1/K-Rev) have been previously described (21) . CSGW, a packagable HIV-1 vector plasmid expressing EGFP, and HIV-1 GagPol expression plasmids have been described (1, 13) . Plasmids expressing various human APOBEC3 proteins, namely hA3A, hA3B, hA3C, hA3F, and hA3G have been described (6) . Plasmids expressing additional human APOBEC3 proteins (hA3DE and hA3H) were cloned using the same pCMV4-HA vector and HinDIII and XbaI restriction sites.
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Infection assays
To generate infectious HERV-K CON -derived virions, 293T cells in six-well plates were transfected with 1.8µg CCGBX, 0.5 µg pCRVI/Con Gag-PR-Pol, 0.5µg pCR3. 
HERV-K sequence analyses
Full length HERV-K(HML-2) sequences in human genome were identified using a TBLASTX search (www.ensembl.org/Multi/blastview) of the human genome using HERV-K CON Gag sequence as the query sequence. Sixteen unique (by chromosomal location) human-specific full length HERV-K(HML-2) proviruses were identified by cross referencing with insertions The p values that accompany the sequence analyses were calculated by chi-square test of independence to determine whether the frequency at which each nucleotide occurred at each position flanking each mutation was significantly different relative to its expected frequency based on nucleotide composition.
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HERV-K hypermutation assay
Infectious HERV-K CON particles were generated as described above using CCGBX-P in place of CCGBX. Prior to infection, supernatant was supplemented with 10mM MgCl 2 and for 10 s, 72 for 15 s; 30 cycles). Amplified DNA was purified using a gel extraction kit (QIAGEN) and cloned into pCR-Blunt II-TOPO according to the manufacturer's instructions (Invitrogen). To confirm the complete elimination of transfected DNA, we attempted to amplify plasmid sequence using primers targeting the plasmid backbone sequence and the untranslated region of HERV-K using similar PCR conditions. Also, to confirm that the amplified sequences were derived from de novo reverse transcribed DNA, HERV-K particles containing a mutationally inactivated reverse transcriptase were subjected to the same infection procedure and PCR analysis. Twelve clones were sequenced for each APOBEC3 protein studied, as well as the empty vector control, and compared to the original CCGBX-P sequence for evidence of hypermutation.
Western blot analysis
To generate an anti-CA polyclonal antiserum, the N-terminal cleavage site of CA was first determined by Edman sequencing of the putative CA protein isolated from purified HERV-K CON virion particles. As CA is known to be around 30kDa, the position of the C-terminal CA cleavage site was estimated using this molecular weight and the determined position of the CA N-terminus. The deduced CA encoding sequence was cloned into pGEX-6P-1 (GE Healthcare Life Sciences) to express a GST-tagged CA protein that was purified using glutathione-agarose beads. The GST tag was eliminated by PreScission protease cleavage as per manufacturer's instructions (GE Healthcare Life Sciences). The purified recombinant CA protein was used to generate the antiserum (Covance).
Transfected 293T cells were lysed in SDS-PAGE loading buffer and separated on 4-20% gradient SDS-PAGE gels. Proteins were transferred onto nitrocellulose membrane and probed
A C C E P T E D
with anti-HERV-K Gag, anti-HIV-1 CA, or anti-HA (Covance) primary antibodies followed by anti-rabbit or anti-mouse peroxidase conjugates.
RESULTS
Inhibition of HERV-K CON infection by APOBEC3 proteins.
Given our previous observation that HERV-K infectivity can be inhibited by overexpressed hA3F (21), we determined whether other human APOBEC3 proteins that HERV-K might have encountered during its replication could also inhibit HERV-K infection. Although it would be optimal to test infection under physiologically relevant protein levels, the expression level of most APOBEC3 proteins in various tissues is unknown. Moreover, the tissue tropism of HERV-K is unknown. Instead, by titrating the amount of expression vector in our assays, we expressed APOBEC3 proteins at varying, and relatively low, levels that mimicked the range of protein levels at which hA3G, hA3F and hA3B can inhibit HIV-1 infection in the absence of Vif (Fig. 1A , B).
HERV-K CON virus-like particles (VLPs) were generated in 293T cells in the presence of each of the C-terminally HA-tagged human APOBEC3 proteins. Western blot analysis of cell lysates showed that APOBEC3 protein expression varied (Fig. 1A ), but the range of expression levels for most of the proteins overlapped as a result of transfecting varying levels of the corresponding expression plasmids. However, hA3DE and hA3H were comparatively poorly expressed (26). Importantly, HERV-K Gag was expressed equally in all samples ( Fig 1A) . The only exception to this was at high levels of hA3B expression, which appeared to slightly reduce the levels of HERV-K Gag expression. Fresh 293T cells were infected with HERV-K virions generated in the presence of each of the APOBEC3 proteins. As can be seen in Fig. 1B , hA3A, hA3B, and hA3F inhibited HERV-K CON infection by approximately five-fold at the highest concentration tested. Only marginal inhibition of infection restriction was seen with hA3G, while hA3C, hA3DE, and hA3H did not inhibit infection. Clearly, the relative sensitivity of HERV-K to the various APOBEC3 proteins differed from that of HIV-1 (Fig. 1B) .
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Hypermutated HERV-K proviruses in modern human DNA
While several APOBEC3 proteins appeared capable of inhibiting HERV-K infection in vitro, to determine whether restriction of HERV-K infection might have occurred in vivo, we investigated whether evidence of APOBEC3-induced mutation could be found in HERV-K proviruses that are present in modern human DNA. Specifically, we inspected sixteen humanspecific full length HERV-K(HML-2) proviruses and looked for biases in the patterns of mutation therein, relative to the pseudo-ancestral HERV-K CON sequence. Overall, we found that G-to-A and C-to-T substitutions were the most abundant changes in the proviruses as a whole, ( Fig. 2A) , as is typical of the general pattern of nucleotide substitutions that are found in the human genome.
Fourteen HERV-K proviruses showed a comparatively minor increase in the frequency of G-to-A changes and C-to-T changes relative to other changes (Fig 2A) . However, two proviruses, HERV-K60 and HERV-KI, were exceptional in the total quantity and type of changes. Overall, they exhibited similar frequencies of C-to-T mutation as did the other 14 proviruses, but both HERV-K60 and HERV-KI exhibited a very high frequency of G-to-A changes relative to the HERV-K CON (Fig 2A, B) . Indeed, each of these individual proviruses had more G-to-A
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mutations than the other fourteen proviruses combined; two thirds and half of all the changes in K60 and KI, respectively, were G-to-A mutations ( Fig. 2A) .
To ensure that the exceptional properties of the two apparently hypermutated proviruses was not due to their insertion into an unusually hypermutated region of the human genome, we examined 2 kb of flanking genomic sequence at each end of the two proviruses for evidence of hypermutation. Specifically, we examined changes between the equivalent loci in humans as compared to chimpanzees. This is a conservative approach, since the HERV-K insertions are absent in chimpanzees and have, therefore, been resident in the human genome for less time than the flanking sequences have been diverging. We found, as expected, that G-to-A, C-to-T, and reciprocal A-to-G and T-to-C changes were the most abundant in comparisons of the human and chimpanzee flanking sequences ( Fig. 2A) . However, G-to-A changes did not greatly outnumber other changes, suggesting that that the apparent hypermutation in the inserted proviruses occurred independently of the genomic context sequence, likely prior to their integration.
In addition to the 16 aforementioned proviruses, additional human-specific partial HERV-K sequences that lacked LTRs, as well as HERV-K proviruses (defined as Group N by Romano et al) that were not human-specific, and group N CERV-K proviruses (chimpanzee counterparts of HERV-K) including four chimpanzee specific insertions were also examined, as were related Group O proviruses. No evidence of hypermutation was evident in these sequences (data not shown). This series of events would lead to an overabundance of plus strand C to T changes with G in the +1 position relative to the C-to-T mutation (CG to TG). Conversely, the same deamination event on the minus strand would lead to plus strand G-to-A changes with an overabundance of C at the -1 position relative to the mutated nucleotide (CG to CA). Indeed, we found that in most of the HERV-K proviruses examined (the fourteen non-hypermutated proviruses), G-to-A changes were significantly enriched for C in the -1 position (Fig 3A) , suggesting most G-to-A changes were a result of spontaneous cytosine deamination, as would be expected of DNA elements that are long term residents of the human genome.
Flanking nucleotide characteristics of G-to-A changes in hypermutated HERV-K proviruses.
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To determine whether the excessive G-to-A changes present in HERV-K60 and HERV-KI were indicative of APOBEC3-induced hypermutation, and if so, to determine the identity of the responsible protein, we examined the nucleotides flanking the G-to-A changes (Fig. 3B) . At least some of the APOBEC3 proteins have signature dinucleotide preferences; for example, hA3B and hA3F prefer to deaminate cytosines within TC dinucleotides (resulting in GA to AA mutations on the viral plus strand), while hA3G exhibits a bias for deaminating CC dinucleotide (leading to plus strand GG to AG changes). In fact, of the human APOBEC3 proteins that have been examined, only hA3G exhibits the bias toward GG to AG changes. In both HERV-K60 and HERV-KI, a strong GG dinucleotide bias was detected at positions where G-to-A changes occurred ( Fig. 3B-D) . This preference indicates that hA3G was likely responsible for the excessive G-to-A mutation in HERV-K60 and HERV-KI. In other proviruses, and the genomic DNA flanking HERV-K60 and HERV-KI, no such dinucleotide preference was detected (Fig 3A, A C C E P T E D data not shown). Furthermore, a strong, statistically significant bias for GGG trinucleotides at Gto-A mutated positions also evident upon examination of the third nucleotide in all GG to AG substitutions ( Fig. 3 C, D) . Notably, the GGG preference has been detected in previous studies of hA3G with and Vif-deficient HIV-1 (43), further supporting the notion that hA3G was responsible for the excessive G-to-A mutation in HERV-KI and HERV-K60.
Hypermutation of HERV-K by APOBEC3 proteins during in vitro replication.
To test whether the in vivo hypermutation changes could be recapitulated in vitro, we generated HERV-K virions in the presence of each human APOBEC3 protein using HERV-K packaging construct CCGBX-P, which contains HIV-1 sequence in the 3' LTR to allow selective amplification of newly synthesized HERV-K in a background of existing HERV-K proviruses present in human cells. A 762bp sequence of nascent HERV-K DNA was thus amplified using primers targeting the EGFP insert in the vector genome and the inserted HIV-1 sequence. Two controls were done to establish the success of this strategy, and to show that DNAse treatment reduced contaminating plasmid DNA in the virion preparations to sub-detectable levels. First, PCR amplifications were done using primers targeting the plasmid backbone. Second, infections were done using virions harboring an inactivating point mutation in the HERV-K reverse transcriptase. In both cases, PCR products were not detected, indicating that the sequences generated following HERV-K infection genuinely represented infection-dependent, de novo synthesized, HERV-K DNA.
We found that hA3A, hA3B, hA3F, and hA3G were capable of inducing hypermutation of HERV-K during in vitro infection. However the patterns and frequency of hypermutation were different (Fig. 4A) . In particular, nearly all HERV-K clones generated in the presence of
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on October 22, 2017 by guest http://jvi.asm.org/ Downloaded from hA3G had G-to-A mutations, but each had a low to moderate number of changes (median of six G-to-A changes per clone). Conversely, hA3A, hA3B, and hA3F each induced hypermutation in a minority of clones, but hA3A and hA3B hypermutated clones had a very high burden of mutations (37 changes for the sole hA3A hypermutated clone, and a median of 43.5 G to A changes for hA3B hypermutated clones). Only a few changes were seen in HERV-K DNA generated in the presence of hA3F (median of four changes per clone).
Of the four human APOBEC3 proteins found to hypermutate HERV-K in vitro, only hA3G exhibited the GG dinucleotide and GGG trinucleotide bias for the generation of G-to-A mutations (Fig 4A, B) as has previously bee reported for hA3G mutation of HIV-1. Moreover, hA3F and hA3B exhibited the expected GA dinucleotide bias at positions where G-to-A mutations were generated (Fig 4A, B) . hA3A also showed the same GA bias, with the caveat that only a single HERV-K CON clone was found to be mutated by hA3A (Fig 4A, B) . Hence, among all seven of the human APOBEC3 proteins, four appear intrinsically capable of inducing hypermutation in HERV-K, but only hA3G was capable of hypermutating HERV-K during in vitro infection with a characteristic bias that very closely mimicked that associated with mutations found in the endogenous HERV-K60 and HERV-KI proviruses (compare Fig. 3B and Fig 4B) . Moreover, when we compared the 273 bp of HERVK CON sequence that was analyzed in the hA3G mutagenesis assay with the corresponding sequence in HERV-K60 and HERV-KI, 10 out of the possible 75 G-to-A mutations were found in either or both HERV-K60 and HERV-KI while 15 out of the possible 75 G-to-A mutations were represented in corresponding sequences that mutated by hA3G during in vitro infection (Fig. 5A, B) . Notably, 6 of these G-to-A mutations were at identical positions, a highly significant correlation (p=0.003, Fishers exact When comparing full-length human-specific HERV-K proviruses to HERV-K CON , which approximates to an ancestral sequence for the most recent expansion of HERV-K proviruses in humans, we found an abundance of G-to-A and C-to-T substitutions. These substitutions, the most common change found in genomes, can occur when DNA methyltransferase methylates cytosines in CG dinucleotides to 5-methylcytosine, which spontaneously deaminates to thymine, resulting in CG to TG change. These methylation events, important for development via genomic imprinting and X chromosome inactivation, can also silence retroelements. This effect has been demonstrated in mice, where knocking out DNA methyltransferase Dnmt1 or Dnmt3L leads to
transcriptional activation of mouse retroelements intracisternal A particles (IAP) and LINE-1 (9, 39). In addition, previous studies of a selection of HERV-K LTRs in teratocarcinoma cell line Tera-1 showed that methylation and transcription are inversely related (20). Given these two facts, one would expect to find that HERV-K proviruses would be cytosine-methylated by the host, and consequently G-to-A and C-to-T mutations substitutions might be abundant. This was indeed the case, and in 14 of 16 HERV-K proviruses examined, the CG dinucleotide methylation/spontaneous deamination pathway appeared to be the major source of G-to-A and Cto-T mutations.
Another common cause of G-to-A, and less frequently C-to-T (7), mutations changes in viral DNA is APOBEC3-mediated cytidine deamination. Fortuitously, the two events are easily distinguished. DNA methyltransferases methylate cytosines in CG dinucleotide, while APOBEC proteins deaminate cytosines in XC dinucleotide, where X can differ depending on the APOBEC protein that is responsible for deamination. Hence, by examining the nucleotides immediately 5' and 3' to the mutated cytosine, we can largely assign G-to-A and C-to-T changes to either mechanism. One exception is when both DNA methyltransferase and APOBEC preferred nucleotides flank the altered cytosine, such as CCG trinucleotide, where CC represents the dinucleotide preference of hA3G, and CG the preference of DNA methyltransferase. However, exclusion of these ambiguous samples in our analyses did not alter the conclusions.
The characteristics of HERV-K hypermutation found in both in vivo and in vitro match several of the characteristics previously observed in the context of APOBEC-induced mutation in other retrovirus infections. First, G-to-A constituted a large fraction of total mutations in HERV-K60 and HERV-KI, as has previously been found for hypermutated viral sequences in HIV and HBV infected patients (17, 31, 36, 38) . Furthermore, the GGG trinucleotide preference found
during in vitro HERV-K infection in the presence of hA3G has been documented in HIV-1 infection assays by several groups (6, 41, 43) . The combination of these two major characteristics found in HERV-K60 and HERV-KI, plus the failure of any other human APOBEC3 protein to induce a similar pattern of mutation during HERV-K replication in vitro make a strong argument for hA3G as the sole source of hypermutation in ancient HERV-K proviruses.
Another reported characteristic of viral hypermutation by hA3G is the gradient of changes along the viral genome. This characteristic is thought to derive from the positiondependent length of time that the nascent viral DNA is in the form of ssDNA, the preferred nucleic substrate of hA3G. However this was not observed in the HERV-K60 and HERV-KI sequences (data not shown). The reasons for this are unclear at present. Nonetheless, our ability to fairly precisely recreate the hypermutation patterns present in ancient proviruses specifically using hA3G during in vitro HERV-K replication assays suggests that the interaction between this protein and HERV-K occurred, and was physiologically and evolutionarily relevant. HERV-K is therefore an eminently reasonable candidate for an infectious agent that has applied selective pressure on A3G during primate evolution. However, we do note that HERV-K is but one of a number of agents that could potentially have imposed selective pressure on antiretroviral 
